Review Article
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
Table 1
PPARs expression and respective ligands.
| Types | Major distribution | Targets |
| Agonist |
| PPARα | Liver, heart, kidney | Fenofibrate | Clofibrate | (FGF21) | (G0S2) |
| PPARβ/δ | Skeletal muscle, liver | GW0742 | GW501516 | MBX-8025 |
| PPARγ | Adipose tissue | TZDs | (rosiglitazone, pioglitazone) | Palmitate | PGC1 |
| PPARα/δ | | GFT505 (elafibranor) |
| PPARα/γ | | Tesaglitazar | | Glitazars (saroglitazar) |
| Antagonist |
| PPARγ | | Isorhamnetin (quercetin) |
| PPARα/γ | | Z-551 |
|
|